Abstract:Alzheimer's disease (AD), Parkinson's disease (PD), Frontotemporal Dementia (FTD), and Amyotrophic lateral sclerosis (ALS) are complex and fatal neurodegenerative diseases. While current treatments for these diseases do alleviate some symptoms, there is an imperative need for novel treatments able to stop their progression. For all of these ailments, most cases occur sporadically and have no known genetic cause. Only a small percentage of patients bear known mutations which occur in a multitude of genes. Hence, it is clear that genetic factors alone do not explain disease occurrence. Chromatin, a DNA-histone complex whose basic unit is the nucleosome, is divided into euchromatin, an open form accessible to the transcriptional machinery, and heterochromatin, which is closed and transcriptionally inactive. Protruding out of the nucleosome, histone tails undergo post-translational modifications (PTMs) including methylation, acetylation, and phosphorylation which occur at specific residues and are connected to different chromatin structural states and regulate access to transcriptional machinery. Epigenetic mechanisms, including histone PTMs and changes in chromatin structure, could help explain neurodegenerative disease processes and illuminate novel treatment targets. Recent research has revealed that changes in histone PTMs and heterochromatin loss or gain are connected to neurodegeneration. Here, we review evidence for epigenetic changes occurring in AD, PD, and FTD/ALS. We focus specifically on alterations in the histone PTMs landscape, changes in the expression of histone modifying enzymes and chromatin remodelers as well as the consequences of these changes in heterochromatin structure. We also highlight the potential for epigenetic therapies in neurodegenerative disease treatment. Given their reversibility and pharmacological accessibility, epigenetic mechanisms provide a promising avenue for novel treatments. Altogether, these findings underscore the need for thorough characterization of epigenetic mechanisms and chromatin structure in neurodegeneration.

Novel histone post-translational modifications in Alzheimer's disease: current advances and implications

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics

The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer's Disease.

A new perspective on Alzheimer’s disease: m6A modification

Aberrant histone turnover in Alzheimer's disease

5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity

The Development Prospection of HDAC Inhibitors As a Potential Therapeutic Direction in Alzheimer’s Disease

The Development Prospection of HDAC Inhibitors As a Potential Therapeutic Direction in Alzheimer's Disease.

Histone acetylation in an Alzheimer's disease cell model promotes homeostatic amyloid-reducing pathways

Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification

Transcriptional Regulation of Lncrna Genes by Histone Modification in Alzheimer’s Disease

The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model

The Epigenetics of Alzheimer’s Disease: Factors and Therapeutic Implications

Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology

Function and Mechanism of Novel Histone Posttranslational Modifications in Health and Disease

Subcellular proteomics insights into Alzheimer's disease development

Positive Feedback Regulation of Microglial Glucose Metabolism by Histone H4 Lysine 12 Lactylation in Alzheimer's Disease

Epigenetic regulation in Alzheimer’s disease: is it a potential therapeutic target?

Novel Disease-Modifying Therapies for Alzheimer's Disease.

Defective Autophagy and Mitophagy in Alzheimer's Disease: Mechanisms and Translational Implications